Kevin Tan
Director of Finance/CFO bei SOLID BIOSCIENCES INC.
Vermögen: 123 983 $ am 31.03.2024
Profil
Kevin Tan is currently the Chief Financial Officer at Solid Biosciences, Inc. He previously worked as Treasurer at Sarepta Therapeutics, Inc. from 2018 to 2021 and as Chief Financial & Accounting Officer at Selecta Biosciences, Inc. from 2021 to 2022.
Prior to his roles in the biotech industry, he was a Senior Portfolio Manager at CPP Investments Ltd.
Mr. Tan received his undergraduate degree from Queen's University, his graduate degree from Princeton University, and his MBA from The University of Chicago Booth School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SOLID BIOSCIENCES INC.
0,02% | 13.02.2024 | 9 308 ( 0,02% ) | 123 983 $ | 31.03.2024 |
Aktive Positionen von Kevin Tan
Unternehmen | Position | Beginn |
---|---|---|
SOLID BIOSCIENCES INC. | Director of Finance/CFO | 09.01.2023 |
Ehemalige bekannte Positionen von Kevin Tan
Unternehmen | Position | Ende |
---|---|---|
CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 28.11.2022 |
SAREPTA THERAPEUTICS, INC. | Treasurer | 01.09.2021 |
CPP Investments Ltd.
CPP Investments Ltd. Investment ManagersFinance Part of Helical Plc, CPP Investments Ltd. is a British company that provides investment management services. The private company is based in London, UK. CPP Investments was founded in 1988. | Corporate Officer/Principal | - |
Ausbildung von Kevin Tan
Queen's University | Undergraduate Degree |
Princeton University | Graduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
SOLID BIOSCIENCES INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
CPP Investments Ltd.
CPP Investments Ltd. Investment ManagersFinance Part of Helical Plc, CPP Investments Ltd. is a British company that provides investment management services. The private company is based in London, UK. CPP Investments was founded in 1988. | Finance |